Chung, Kuei-Pin http://orcid.org/0000-0003-1916-8068
Hsu, Chia-Lang http://orcid.org/0000-0002-7447-8045
Fan, Li-Chao
Huang, Ziling
Bhatia, Divya http://orcid.org/0000-0002-8236-3440
Chen, Yi-Jung
Hisata, Shu
Cho, Soo Jung
Nakahira, Kiichi
Imamura, Mitsuru http://orcid.org/0000-0002-2813-4102
Choi, Mary E.
Yu, Chong-Jen
Cloonan, Suzanne M.
Choi, Augustine M. K.
Funding for this research was provided by:
National Taiwan University Hospital (NTUH.108-N03)
U.S. Department of Health & Human Services | National Institutes of Health (K08 HL138285, KL2-TR-002385, R01 HL132198, R00 HL125899, P01 HL114501, R01 HL132198, R01 HL133801)
American Lung Association (RG-512060)
Article History
Received: 9 December 2018
Accepted: 1 July 2019
First Online: 29 July 2019
Competing interests
: The spouse of M.E.C. is a co-founder, shareholder and serves on the Scientific Advisory Board of Proterris, Inc. A.M.K.C. is a cofounder, stock holder and serves on the Scientific Advisory Board for Proterris, which develops therapeutic uses for carbon monoxide. A.M.K.C. also has a use patent on CO. He served on the TEVA Advisory Board meeting as a consultant on July 12–13, 2018. The remaining authors declare no competing interests.